Nadia Regis
Women's Health · Jbsa Lackland, TXNPI 1427206341
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $977 and has fallen 94.3% since, to $56 in 2025. Among women's health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 160 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$501
- AbbVie$476
- Evofem Biosciences, Inc.$286
- Daiichi Sankyo Inc.$257
- Astellas Pharma US Inc$182
- Exeltis, USA Inc.$170
- plus $1K from 20 others
What the payments were for
- Food & beverage$2,85197%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 22 | $501 |
| AbbVie | 29 | $476 |
| Evofem Biosciences, Inc. | 16 | $286 |
| Daiichi Sankyo Inc. | 15 | $257 |
| Astellas Pharma US Inc | 6 | $182 |
| Exeltis, USA Inc. | 9 | $170 |
| Therapeuticsmd, Inc. | 13 | $156 |
| Biohaven Pharmaceuticals, Inc. | 5 | $150 |
| Shield Therapeutics Inc | 8 | $148 |
| Myovant Sciences Inc. | 6 | $101 |
| Merck | 5 | $85 |
| Avion Pharmaceuticals | 5 | $76 |
| Sumitomo Pharma America, Inc. | 4 | $70 |
| Agile Therapeutics, Inc. | 3 | $46 |
| Davol Inc. | 2 | $33 |
| Hologic Sales And Service, LLC | 1 | $31 |
| Pfizer | 1 | $25 |
| Biogen | 1 | $23 |
| BD | 1 | $22 |
| Johnson & Johnson | 1 | $22 |
| Coopersurgical, Inc. | 1 | $17 |
| Medicem Inc. | 1 | $16 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Aspira Women's Health Inc | 1 | $15 |
| Lupin Inc. | 1 | $14 |
| Organon | 2 | $12 |
How this compares
$2,951 in reported general payments places this provider in the 90th percentile of 609 women's health providers in Texas.
Other women's health in Jbsa Lackland
- Evelyn TingGrapevine$89K
- Christina TrumanWaco$70K
- Kayla CastanedaEl Paso$53K
- Shelagh LarsonFort Worth$43K
- Amanda ArmondAustin$17K
- Joann St PierreHouston$15K
- Christina BlancoEl Paso$14K
- Ricshonda MilburnGalveston$13K
- Sandra EastlingLubbock$12K
- Lori WinkHouston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.